ReviewWorld journal of oncology2023
Adult Primary Retroperitoneal Lymphangioma: Updated Facts.
Review in World journal of oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Imaging features and clinical management of mesenteric cavernous lymphangioma: A case report and literature review.Oncology letters · 2026Article
- Adult-onset primary retroperitoneal cystic lymphangioma displacing the inferior vena cava: laparoscopic management of a triple-rarity case from Nepal and review of recent literature.International journal of surgery case reports · 2026Article
- Giant Recurrent Retroperitoneal and Ischioanal Lymphangioma in an Adult: A Case Report.Reports (MDPI) · 2026Article
- Imaging approach to retroperitoneal vascular tumors: a narrative review.Abdominal radiology (New York) · 2026Review
- Pelvic Lymphangioma: The Purpose of a Clinical Case.Cureus · 2026Article
- Retroperitoneal cavernous lymphangioma in an adult: a case report and review of the literature.Frontiers in oncology · 2026Article
- Case Report: Giant congenital hydronephrosis presenting as massive retroperitoneal cystic lesion with literature review.Frontiers in surgery · 2026Article
- In vitro fertilization-embryo transfer resulting in a live birth in a woman with benign multicystic peritoneal mesothelioma: A case report.Fujita medical journal · 2025Article
- Retroduodenal lymphangiomyoma: A rare cause of abdominal pain - A case report.International journal of surgery case reports · 2025Article
- Article
- Retroperitoneal cystic lymphangioma coexisting with a uterine fibroid in a 42-year-old woman: A case report.Case reports in women's health · 2024Article
- Characteristics of adult retroperitoneal lymphangioma: a single center Chinese cohort study of 15 cases.Discover oncology · 2024Article
- Laparoscopic-assisted sclerotherapy in pediatric retroperitoneal lymphatic malformations.Frontiers in pediatrics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphangioma is a rare, benign tumor of the lymphatic system. It is believed to be a congenital malformation, when part of the lymphatic channels fail to connect to the main lymphatic system. Lymphangioma is a tumor of the pediatric age, with 50% of patients presenting at birth. The head and neck are the main affected sites (75%), while the retroperitoneal cavity is the least affected area, and comprises less than 1% of cases. Adult lymphangioma is an extremely rare tumor, and adult retroperitoneal lymphangioma (ARL) is even a rarer tumor. Over the last two decades, we have experienced a significant increase in reports published in the English literature discussing ARL. As reports have increased, several questions about previously known facts regarding this tumor arose: For years, it was known that ARL is usually an asymptomatic tumor which is incidentally found - is it a true claim? Is abdominal magnetic resonance imaging the radiological test of choice for diagnosis? What is the best therapeutic option? The main aim for this article is to review the current and old English literature concerning ARL, in order to collect data regarding demographic features, clinical presentation, imaging tests used for diagnosis, therapeutic options and follow-up. This in turn will give precise updated answers for the previous questions. In addition, it will raise awareness for the treating physician regarding the most effective approach for early diagnosis and best therapeutic option to be selected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.